Results 131 to 140 of about 724,485 (248)
We assessed the prognostic ability of the Immunoscore and PD‐L1 or PD‐L2 expression in pStage III GC patients by immunohistochemistry. The results showed that Immunoscore was an independent prognostic factor in differentiated GC, but not in undifferentiated GC.
Yoshiro Yukawa +13 more
wiley +1 more source
We have evaluated interinstitutional variation to verify the generalization and standardization of gastric cancer surgery from a supplementary analysis of the randomized phase III trial JCOG1001. Although there was some degree of interinstitutional variation in short‐ and long‐term outcomes after standard gastric surgery, we found no correlation ...
Motohiro Hirao +14 more
wiley +1 more source
Recommendations of the Stiglitz-Sen-Fitoussi Report: A few illustrations [PDF]
In September 2009 the Stiglitz-Sen-Fitoussi Commission submitted its report on the measurement of economic performance and social progress. The report is based on a large body of applied research work conducted in recent years in various fields of the ...
D. BLANCHET, M. CLERC, M. GAINI
core
Fusobacterium nucleatum contributes to the progression of ESCC by inducing NF‐κB–mediated inflammatory signaling in tumor cells and promoting CAFs activation. Its presence may facilitate immune exclusion and tumor invasion through stromal remodeling. Furthermore, F.
Takashi Ofuchi +9 more
wiley +1 more source
This review critically reassesses our prior hypothesis and proposes a revised anatomical model of the fusion fascia that is broadly applicable to GI cancer surgeries grounded in the principles of mesenteric resection. Our synthesis suggests that the fusion fascia is neither a dense connective tissue membrane nor a remnant of mesothelial fusion, but ...
Hisashi Shinohara +9 more
wiley +1 more source
Total Neoadjuvant Therapy for Rectal Cancer: Why Japan Says “Not Yet”
ABSTRACT Total neoadjuvant therapy (TNT) has rapidly gained global acceptance as a standard treatment for locally advanced rectal cancer (LARC). Supported by multiple phase III trials, TNT improves pathological complete response (pCR) rates, enhances systemic control, and expands opportunities for non‐operative management (NOM).
Kay Uehara +4 more
wiley +1 more source
ABSTRACT Aim To investigate the factors associated with BWL after gastrectomy using data from the phase III trial (JCOG1001). Methods This post hoc analysis included 728 patients from the JCOG1001. The percentage of BWL (%BWL) was defined as the proportion of decrease in body weight immediately before adjuvant chemotherapy initiation compared with that
Takanobu Yamada +16 more
wiley +1 more source
ABSTRACT Aim Spigelman stage IV duodenal polyposis (SP‐stage IV DP) is associated with high duodenal cancer risk in patients with familial adenomatous polyposis (FAP). This study evaluated the surgical and oncological outcomes of pancreas‐sparing total duodenectomy (PSTD) as a surgical prophylaxis for severe duodenal polyposis in FAP.
Takehiro Shiraishi +8 more
wiley +1 more source
This prospective randomized trial evaluated whether prehabilitation, exercise and nutrition intervention, enhance skeletal muscle mass during neoadjuvant chemotherapy in older patients with esophageal cancer undergoing esophagectomy. We also investigated whether exercise alone was sufficient to increase skeletal muscle mass, and whether nutritional ...
Keijiro Sugimura +7 more
wiley +1 more source

